Aruffo A - Search Results

1

Anti-CD40 therapy extends renal allograft survival in rhesus macaques.

Pearson TC, Trambley J, Odom K, Anderson DC, Cowan S, Bray R, Lin A, Hollenbaugh D, Aruffo A, Siadak AW, Strobert E, Hennigar R, Larsen CP. Pearson TC, et al. Among authors: aruffo a. Transplantation. 2002 Oct 15;74(7):933-40. doi: 10.1097/00007890-200210150-00006. Transplantation. 2002. PMID: 12394833

2

CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.

Larsen CP, Alexander DZ, Hollenbaugh D, Elwood ET, Ritchie SC, Aruffo A, Hendrix R, Pearson TC. Larsen CP, et al. Among authors: aruffo a. Transplantation. 1996 Jan 15;61(1):4-9. doi: 10.1097/00007890-199601150-00002. Transplantation. 1996. PMID: 8560571

3

Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade.

Elwood ET, Larsen CP, Cho HR, Corbascio M, Ritchie SC, Alexander DZ, Tucker-Burden C, Linsley PS, Aruffo A, Hollenbaugh D, Winn KJ, Pearson TC. Elwood ET, et al. Among authors: aruffo a. Transplantation. 1998 Jun 15;65(11):1422-8. doi: 10.1097/00007890-199806150-00002. Transplantation. 1998. PMID: 9645796

4

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC. Larsen CP, et al. Among authors: aruffo a. Nature. 1996 May 30;381(6581):434-8. doi: 10.1038/381434a0. Nature. 1996. PMID: 8632801

5

The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.

Niimi M, Pearson TC, Larsen CP, Alexander DZ, Hollenbaugh D, Aruffo A, Linsley PS, Thomas E, Campbell K, Fanslow WC, Geha RS, Morris PJ, Wood KJ. Niimi M, et al. Among authors: aruffo a. J Immunol. 1998 Nov 15;161(10):5331-7. J Immunol. 1998. PMID: 9820506

6

The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.

Ochs HD, Hollenbaugh D, Aruffo A. Ochs HD, et al. Among authors: aruffo a. Semin Immunol. 1994 Oct;6(5):337-41. doi: 10.1006/smim.1994.1042. Semin Immunol. 1994. PMID: 7532462 Review.

7

Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease.

Aruffo A, Hollenbaugh D. Aruffo A, et al. Curr Opin Immunol. 2001 Dec;13(6):683-6. doi: 10.1016/s0952-7915(01)00279-5. Curr Opin Immunol. 2001. PMID: 11677090 Review.

8

The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.

Ochs HD, Hollenbaugh D, Aruffo A. Ochs HD, et al. Among authors: aruffo a. Res Immunol. 1994 Mar-Apr;145(3):210-5; discussion 244-9. Res Immunol. 1994. PMID: 7527577 Review. No abstract available.

9

Pillars article: long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996. 381: 434-438. 1996.

Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC. Larsen CP, et al. Among authors: aruffo a. J Immunol. 2011 Mar 1;186(5):2693-7. J Immunol. 2011. PMID: 21325218 No abstract available.

10

Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction.

Bajorath J, Chalupny NJ, Marken JS, Siadak AW, Skonier J, Gordon M, Hollenbaugh D, Noelle RJ, Ochs HD, Aruffo A. Bajorath J, et al. Among authors: aruffo a. Biochemistry. 1995 Feb 14;34(6):1833-44. doi: 10.1021/bi00006a003. Biochemistry. 1995. PMID: 7531493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters